Taiwan · Delayed Price · Currency is TWD Altair Engineering Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 4.12 billion. The enterprise value is 3.97 billion.
| Market Cap | 4.12B |
| Enterprise Value | 3.97B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Onyx Healthcare has 39.01 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 39.01M |
| Shares Outstanding | 39.01M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 12.00% |
| Owned by Institutions (%) | 0.02% |
| Float | 12.26M |
Valuation Ratios
The trailing PE ratio is 33.37.
| PE Ratio | 33.37 |
| Forward PE | n/a |
| PS Ratio | 3.09 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | 37.41 |
| P/OCF Ratio | 33.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.79, with an EV/FCF ratio of 36.12.
| EV / Earnings | 32.27 |
| EV / Sales | 2.98 |
| EV / EBITDA | 24.79 |
| EV / EBIT | 28.30 |
| EV / FCF | 36.12 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.86 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.31 |
| Debt / FCF | 2.10 |
| Interest Coverage | 17.60 |
Financial Efficiency
Return on equity (ROE) is 8.34% and return on invested capital (ROIC) is 2.95%.
| Return on Equity (ROE) | 8.34% |
| Return on Assets (ROA) | 2.26% |
| Return on Invested Capital (ROIC) | 2.95% |
| Return on Capital Employed (ROCE) | 4.69% |
| Revenue Per Employee | 11.12M |
| Profits Per Employee | 1.03M |
| Employee Count | 120 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 3.28 |
Taxes
In the past 12 months, Onyx Healthcare has paid 18.40 million in taxes.
| Income Tax | 18.40M |
| Effective Tax Rate | 13.01% |
Stock Price Statistics
The stock price has decreased by -40.34% in the last 52 weeks. The beta is 0.32, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -40.34% |
| 50-Day Moving Average | 113.79 |
| 200-Day Moving Average | 140.41 |
| Relative Strength Index (RSI) | 40.93 |
| Average Volume (20 Days) | 29,333 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.33 billion and earned 123.15 million in profits. Earnings per share was 3.16.
| Revenue | 1.33B |
| Gross Profit | 454.43M |
| Operating Income | 79.87M |
| Pretax Income | 141.48M |
| Net Income | 123.15M |
| EBITDA | 95.43M |
| EBIT | 79.87M |
| Earnings Per Share (EPS) | 3.16 |
Balance Sheet
The company has 381.13 million in cash and 230.61 million in debt, giving a net cash position of 150.52 million or 3.86 per share.
| Cash & Cash Equivalents | 381.13M |
| Total Debt | 230.61M |
| Net Cash | 150.52M |
| Net Cash Per Share | 3.86 |
| Equity (Book Value) | 1.50B |
| Book Value Per Share | 38.19 |
| Working Capital | 405.50M |
Cash Flow
In the last 12 months, operating cash flow was 121.76 million and capital expenditures -11.74 million, giving a free cash flow of 110.02 million.
| Operating Cash Flow | 121.76M |
| Capital Expenditures | -11.74M |
| Free Cash Flow | 110.02M |
| FCF Per Share | 2.82 |
Margins
Gross margin is 34.07%, with operating and profit margins of 5.99% and 9.23%.
| Gross Margin | 34.07% |
| Operating Margin | 5.99% |
| Pretax Margin | 10.61% |
| Profit Margin | 9.23% |
| EBITDA Margin | 7.15% |
| EBIT Margin | 5.99% |
| FCF Margin | 8.25% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | -20.74% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 136.08% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 3.44% |
| Earnings Yield | 2.99% |
| FCF Yield | 2.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 6.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.6 |
| Piotroski F-Score | 5 |